Skip to main content
. 2017 Jun 1;27(5):403–412. doi: 10.1089/cap.2015.0146

FIG. 1.

FIG. 1.

Combined study design and dosing for MEM-MD-57A Part 2 and the open-label extension (OLEX). Dose titration in MEM-MD-67 only for participants who were previously randomized to placebo. Participants taking memantine ER during MEM-MD-57A continued with same dose.